½ÃÀ庸°í¼­
»óǰÄÚµå
1579306

ÀÇ·á ºÐ¾ß eConsent ½ÃÀå : Àü°³ ÇüÅ ÃÖÁ¾»ç¿ëÀÚ, ¼Ö·ç¼Ç, ±¸¼º¿ä¼Ò, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

eConsent in Healthcare Market by Deployment Mode (Cloud-Based, On-Premises), End User (Clinics, Hospitals, Pharmaceutical Companies), Solution, Component, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á ºÐ¾ß eConsentÀÇ ½ÃÀåÀº 2023³â 4¾ï 3,676¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 4¾ï 7,405¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 9.17% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 8¾ï 753¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á ºÐ¾ß eConsent´Â ±âÁ¸ÀÇ Á¾ÀÌ ±â¹Ý »çÀü µ¿ÀÇ ÇÁ·Î¼¼½º¸¦ µðÁöÅÐÈ­ÇÑ °ÍÀ¸·Î, ÀÓ»ó½ÃÇè, ¼ö¼ú, ÀÏ»óÀûÀÎ Ä¡·á¿¡¼­ ȯÀÚÀÇ ÀÌÇØ¿Í Âü¿©¸¦ ³ôÀ̱â À§ÇØ ±â¼úÀ» Ȱ¿ëÇÕ´Ï´Ù. eConsentÀÇ Çʿ伺Àº Ä¡·áÀÇ º¹À⼺, ȯÀÚ ÀνÄÀÇ Áõ°¡, »çÀü µ¿ÀÇ ¹®¼­È­¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°Ç µîÀ¸·Î ÀÎÇØ °­Á¶µÇ°í ÀÖÀ¸¸ç, ÀÓ»ó ¿¬±¸ ½ÃÇè¿¡¼­ ÀÏ¹Ý ÀÇ·á ÀýÂ÷¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµÇ¾î ȯÀÚ Âü¿©¸¦ ÃËÁøÇϰí, µ¥ÀÌÅÍÀÇ Á¤È®¼ºÀ» Çâ»ó½Ã۸ç, ¹ýÀû ¹× À±¸®Àû Ç¥ÁØÀ» ÁؼöÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¹ýÀû, À±¸®Àû ±âÁØ Áؼö¸¦ º¸ÀåÇÕ´Ï´Ù. eConsent ½ÃÀåÀÇ ¼ºÀåÀº µðÁöÅÐ ÀÇ·á ±â¼úÀÇ ¹ßÀü, ¿ø°ÝÀÇ·áÀÇ È®»ê, È¿À²ÀûÀΠȯÀÚ µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛÀÇ Çʿ伺¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖÀ¸¸ç, º´¿ø, ¿¬±¸±â°ü, Á¦¾àȸ»ç µîÀÌ ÃÖÁ¾ »ç¿ëó·Î ²ÅÈü´Ï´Ù. Çʿ伺¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. COVID-19 »çÅ´ ÀÇ·á ºÐ¾ßÀÇ µðÁöÅÐ Çõ½ÅÀ» °¡¼ÓÈ­Çϰí, eConsent¸¦ º¸´Ù ±¤¹üÀ§ÇÑ ÀüÀÚ ÀÇ·á ±â·Ï Àü·«ÀÇ ±¸¼º¿ä¼Ò·Î äÅÃÇÏ´Â µ¥ ź·ÂÀ» ÁÖ¾úÀ¸¸ç, eConsent¸¦ AI ¹× ºí·ÏüÀΰú ÅëÇÕÇÏ¿© º¸¾ÈÀ» °­È­Çϰí ȯÀÚ °æÇèÀ» °³ÀÎÈ­ÇÔÀ¸·Î½á ¸ð¹ÙÀÏ ÀÇ·á ÀÎÇÁ¶ó°¡ ¸ð¹ÙÀÏ ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®ÃçÁø ½ÅÈï ½ÃÀå¿¡¼­ eConsentÀÇ È®»êÀÌ ÁøÇàµÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ȯÀÚÀÇ µðÁöÅÐ ¸®ÅÍ·¯½Ã, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, Áö¿ª °£ Àϰü¼º ¾ø´Â ±ÔÁ¦ µîÀÇ °úÁ¦µµ ³²¾ÆÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À庮À» ±Øº¹Çϱâ À§ÇØ Çõ½ÅÀº »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º, ´Ù±¹¾î Áö¿ø, ¾ÈÀüÇÑ µ¥ÀÌÅÍ ±³È¯ ¸ÞÄ¿´ÏÁò¿¡ ÃÊÁ¡À» ¸ÂÃç¾ß ÇÕ´Ï´Ù. µðÁöÅÐ °ÝÂ÷¸¦ ÁÙÀÌ´Â ¹æ¹ýÀ» ¿¬±¸ÇÏ¸é ½ÃÀå ÀáÀç·ÂÀº ´õ¿í Ä¿Áú °ÍÀ¸·Î ¿¹»óµÇ¸ç, eConsent ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀÌ Ä¡¿­Çϸç, ÀÌÇØ°ü°èÀÚµéÀÌ º¸´Ù È¿À²ÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÇ·á IT ¼Ö·ç¼ÇÀ» ã°í Àֱ⠶§¹®¿¡ Å« ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ »óȲÀ» ±Øº¹ÇÏ°í »ç¿ëÀÚ °æÇè ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ´Â ±â¾÷Àº Å« ½ÃÀå Á¡À¯À²À» È®º¸ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. µðÁöÅÐ ÇコÄɾ ÁøÈ­ÇÏ´Â °¡¿îµ¥, ½ÃÀåÀÇ ¸ð¸àÅÒÀ» À¯ÁöÇÏ°í ±â¼úÀÌ È¯ÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ´ÏÁî¿¡ ºÎÇÕÇϵµ·Ï Çϱâ À§Çؼ­´Â Áö¼ÓÀûÀÎ ¿¬±¸°³¹ßÀÌ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 4¾ï 3,676¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 4¾ï 7,405¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 8¾ï 753¸¸ ´Þ·¯
CAGR(%) 9.17%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÇ·á ºÐ¾ß eConsent ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³

ÀÇ·á ºÐ¾ß eConsentÀÇ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • °ü¸® ÇÁ·Î¼¼½º °£¼ÒÈ­¸¦ À§ÇÑ ÀÇ·á ºÐ¾ßÀÇ µðÁöÅÐ ¼Ö·ç¼Ç µµÀÔ Áõ°¡
    • ȯÀÚ Á᫐ ÀÇ·á ¹× µ¿ÀÇ ÀýÂ÷¿¡ ´ëÇÑ Àνİú ¼ö¿ä Áõ°¡
    • ȯÀÚ µ¿ÀÇ °ü¸® ½Ã½ºÅÛ¿¡¼­ µ¥ÀÌÅÍ Á¤È®µµ ¹× º¸¾È °­È­ÀÇ Çʿ伺
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¼­·Î ´Ù¸¥ eConsent ¼Ö·ç¼Ç°ú ÀÇ·á ½Ã½ºÅÛ °£ÀÇ »óÈ£¿î¿ë¼º ºÎÁ·À¸·Î ¿øÈ°ÇÑ ÅëÇÕÀ» ¹æÇØÇÕ´Ï´Ù.
    • ÀÇ·á Àü¹®°¡¿Í ȯÀÚÀÇ µðÁöÅÐ ¸®ÅÍ·¯½Ã ¹× ±â¼ú ¼÷·Ãµµ°¡ ³·¾Æ eConsent µµÀÔ¿¡ ÇѰ谡 ÀÖÀ½
  • ½ÃÀå ±âȸ
    • ÀüÀÚ µ¿ÀÇ ½Ã½ºÅÛ »ç¿ëÀ» ÃËÁøÇÏ´Â Á¤ºÎ ±ÔÁ¦¿Í Àǹ«È­
    • ÀÇ·á ºÐ¾ß eConsent ¼Ö·ç¼ÇÀÇ ±â¼úÀû Áøº¸
  • ½ÃÀå °úÁ¦
    • ÀüÀÚµ¿ÀÇ ½Ã½ºÅÛ°ú ±âÁ¸ ÀüÀڰǰ­±â·Ï(EHR) Ç÷§Æû°úÀÇ ÅëÇÕ °úÁ¦
    • ÀÇ·á±â°ü¿¡¼­ eConsent ¼Ö·ç¼Ç ±¸Ãà ½Ã µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È º¸Àå

Porter's Five Forces : ÀÇ·á ºÐ¾ß eConsentÀÇ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» º¸¿ÏÇϰí, ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á ºÐ¾ß eConsent ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á ºÐ¾ß ÀüÀÚµ¿ÀÇ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÇ·á ºÐ¾ß eConsent ½ÃÀåÀÇ °æÀï »óȲ ÆÄ¾Ç

ÀÇ·á ºÐ¾ß eConsent ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀÇ·á ºÐ¾ß eConsent ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á ºÐ¾ßÀÇ eConsent ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÀÇ·á ºÐ¾ß eConsent ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼®°ú ¼º°øÀÇ ±æ ã±â

ÀÇ·á ºÐ¾ß eConsentÀÇ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸: °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å: ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ, ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÇ·á ºÐ¾ß eConsent ½ÃÀå : Àü°³ Çüź°

  • ¼Ò°³
  • Ŭ¶ó¿ìµå ±â¹Ý
    • ÇÏÀ̺긮µå Ŭ¶ó¿ìµå
    • ÇÁ¶óÀ̺ø Ŭ¶ó¿ìµå
    • ÆÛºí¸¯ Ŭ¶ó¿ìµå
  • ¿ÂÇÁ·¹¹Ì½º

Á¦7Àå ÀÇ·á ºÐ¾ß eConsent ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼Ò°³
  • Ŭ¸®´Ð
  • º´¿ø
  • Á¦¾àȸ»ç
  • ¿¬±¸±â°ü

Á¦8Àå ÀÇ·á ºÐ¾ß eConsent ½ÃÀå : ¼Ö·ç¼Çº°

  • ¼Ò°³
  • µ¿ÀÇ °ü¸®
    • ȯÀÚ µ¿ÀÇ
    • ÀÇ»ç µ¿ÀÇ
  • º¸¾È°ú ÄÄÇöóÀ̾𽺠°ü¸®
  • ¿öÅ©ÇÃ·Î¿ì °ü¸®

Á¦9Àå ÀÇ·á ºÐ¾ß eConsent ½ÃÀå : ±¸¼º¿ä¼Òº°

  • ¼Ò°³
  • ¼­ºñ½º
    • ÄÁ¼³ÆÃ
    • ±¸Çö
    • Áö¿ø°ú À¯Áö°ü¸®
  • ¼ÒÇÁÆ®¿þ¾î

Á¦10Àå ÀÇ·á ºÐ¾ß eConsent ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ÀÓ»ó½ÃÇè
  • µ¥ÀÌÅÍ ¼öÁý
  • ȯÀÚ µî·Ï
  • ±ÔÁ¦ Áؼö

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á ºÐ¾ß eConsent ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á ºÐ¾ß eConsent ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á ºÐ¾ß eConsent ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Anju Software Inc.
  • ArisGlobal LLC
  • Bioclinica
  • Castor EDC
  • CRF Health
  • Datatrak International Inc.
  • Deloitte Touche Tohmatsu Limited
  • eClinicalWorks LLC
  • Fortenova Group
  • IBM Watson Health
  • ICON plc
  • Medable Inc.
  • Oracle Health Sciences
  • Parexel International Corporation
  • Pharma Intelligence
  • PHT Corporation
  • Qualtrics International Inc.
  • REDCap
  • Signant Health
  • Veeva Systems Inc.
ksm 24.11.07

The eConsent in Healthcare Market was valued at USD 436.76 million in 2023, expected to reach USD 474.05 million in 2024, and is projected to grow at a CAGR of 9.17%, to USD 807.53 million by 2030.

eConsent in healthcare represents the digital version of traditional paper-based informed consent processes, leveraging technology to enhance patient comprehension and participation in clinical trials, surgical procedures, and routine medical treatments. Its necessity is underscored by the growing complexity of medical treatments, heightened patient awareness, and regulatory requirements for informed consent documentation. The application of eConsent ranges from clinical research trials to general medical procedures, where it facilitates patient engagement, improves data accuracy, and ensures compliance with legal and ethical standards. End-use sectors include hospitals, research organizations, and pharmaceuticals, each benefiting from streamlined consent workflows and enhanced patient communication. Growth in the eConsent market is fueled by advancements in digital health technologies, increased adoption of telemedicine, and the need for efficient patient data management systems. The pandemic accelerated digital transformation within healthcare, providing an impetus for eConsent adoption as a component of broader electronic health record strategies. Opportunities lie in integrating eConsent with AI and blockchain for enhanced security and personalized patient experiences, expanding its reach within emerging markets rich in mobile health infrastructure. However, challenges persist, such as patient digital literacy, data privacy concerns, and inconsistent regulations across regions. Innovations should focus on user-friendly interfaces, multilingual support, and secure data exchange mechanisms to overcome these barriers. Researching ways to reduce the digital divide will enhance market potential further. The nature of the eConsent market is dynamic and competitive, with significant growth potential as stakeholders seek more efficient and user-friendly health IT solutions. Companies that can navigate regulatory landscapes and address user experience challenges will be poised to capture substantial market share. As digital health evolves, ongoing research and development are crucial for sustaining market momentum and ensuring technology aligns with patient and provider needs.

KEY MARKET STATISTICS
Base Year [2023] USD 436.76 million
Estimated Year [2024] USD 474.05 million
Forecast Year [2030] USD 807.53 million
CAGR (%) 9.17%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving eConsent in Healthcare Market

The eConsent in Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of digital solutions in healthcare to streamline administrative processes
    • Rising awareness and demand for patient-centric healthcare and consent processes
    • Need for improved data accuracy and security in patient consent management systems
  • Market Restraints
    • Lack of interoperability between different eConsent solutions and healthcare systems impedes seamless integration
    • Limited digital literacy and technological proficiency among healthcare professionals and patients restrict eConsent adoption
  • Market Opportunities
    • Government regulations and mandates promoting the use of electronic consent systems
    • Technological advancements in eConsent in Healthcare solutions
  • Market Challenges
    • Integration challenges of eConsent systems with existing electronic health record (EHR) platforms
    • Ensuring data privacy and security in the deployment of eConsent solutions within healthcare organizations

Porter's Five Forces: A Strategic Tool for Navigating the eConsent in Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the eConsent in Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the eConsent in Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the eConsent in Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the eConsent in Healthcare Market

A detailed market share analysis in the eConsent in Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the eConsent in Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the eConsent in Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the eConsent in Healthcare Market

A strategic analysis of the eConsent in Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the eConsent in Healthcare Market, highlighting leading vendors and their innovative profiles. These include Anju Software Inc., ArisGlobal LLC, Bioclinica, Castor EDC, CRF Health, Datatrak International Inc., Deloitte Touche Tohmatsu Limited, eClinicalWorks LLC, Fortenova Group, IBM Watson Health, ICON plc, Medable Inc., Oracle Health Sciences, Parexel International Corporation, Pharma Intelligence, PHT Corporation, Qualtrics International Inc., REDCap, Signant Health, and Veeva Systems Inc..

Market Segmentation & Coverage

This research report categorizes the eConsent in Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Deployment Mode, market is studied across Cloud-Based and On-Premises. The Cloud-Based is further studied across Hybrid Cloud, Private Cloud, and Public Cloud.
  • Based on End User, market is studied across Clinics, Hospitals, Pharmaceutical Companies, and Research Organizations.
  • Based on Solution, market is studied across Consent Management, Security and Compliance Management, and Workflow Management. The Consent Management is further studied across Patient Consent and Physician Consent.
  • Based on Component, market is studied across Services and Software. The Services is further studied across Consulting, Implementation, and Support and Maintenance.
  • Based on Application, market is studied across Clinical Trials, Data Collection, Patient Enrollment, and Regulatory Compliance.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of digital solutions in healthcare to streamline administrative processes
      • 5.1.1.2. Rising awareness and demand for patient-centric healthcare and consent processes
      • 5.1.1.3. Need for improved data accuracy and security in patient consent management systems
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of interoperability between different eConsent solutions and healthcare systems impedes seamless integration
      • 5.1.2.2. Limited digital literacy and technological proficiency among healthcare professionals and patients restrict eConsent adoption
    • 5.1.3. Opportunities
      • 5.1.3.1. Government regulations and mandates promoting the use of electronic consent systems
      • 5.1.3.2. Technological advancements in eConsent in Healthcare solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Integration challenges of eConsent systems with existing electronic health record (EHR) platforms
      • 5.1.4.2. Ensuring data privacy and security in the deployment of eConsent solutions within healthcare organizations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. eConsent in Healthcare Market, by Deployment Mode

  • 6.1. Introduction
  • 6.2. Cloud-Based
    • 6.2.1. Hybrid Cloud
    • 6.2.2. Private Cloud
    • 6.2.3. Public Cloud
  • 6.3. On-Premises

7. eConsent in Healthcare Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospitals
  • 7.4. Pharmaceutical Companies
  • 7.5. Research Organizations

8. eConsent in Healthcare Market, by Solution

  • 8.1. Introduction
  • 8.2. Consent Management
    • 8.2.1. Patient Consent
    • 8.2.2. Physician Consent
  • 8.3. Security and Compliance Management
  • 8.4. Workflow Management

9. eConsent in Healthcare Market, by Component

  • 9.1. Introduction
  • 9.2. Services
    • 9.2.1. Consulting
    • 9.2.2. Implementation
    • 9.2.3. Support and Maintenance
  • 9.3. Software

10. eConsent in Healthcare Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Trials
  • 10.3. Data Collection
  • 10.4. Patient Enrollment
  • 10.5. Regulatory Compliance

11. Americas eConsent in Healthcare Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific eConsent in Healthcare Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa eConsent in Healthcare Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anju Software Inc.
  • 2. ArisGlobal LLC
  • 3. Bioclinica
  • 4. Castor EDC
  • 5. CRF Health
  • 6. Datatrak International Inc.
  • 7. Deloitte Touche Tohmatsu Limited
  • 8. eClinicalWorks LLC
  • 9. Fortenova Group
  • 10. IBM Watson Health
  • 11. ICON plc
  • 12. Medable Inc.
  • 13. Oracle Health Sciences
  • 14. Parexel International Corporation
  • 15. Pharma Intelligence
  • 16. PHT Corporation
  • 17. Qualtrics International Inc.
  • 18. REDCap
  • 19. Signant Health
  • 20. Veeva Systems Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦